GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDPH.L Share News (DPH)

  • There is currently no data for DPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TOP NEWS: M&S returns to FTSE 100 after four years, Persimmon exits

Wed, 30th Aug 2023 17:55

(Alliance News) - FTSE Russell confirmed on Wednesday that the following changes will take effect to its UK indices from the market open on Monday, September 18, after completing its quarterly review.

-------

FTSE 100 Adds:

-------

Dechra Pharmaceuticals PLC

Diploma PLC

Hikma Pharmaceuticals PLC

Marks & Spencer Group PLC

-----

FTSE 100 Deletes:

-------

Abrdn PLC

Hiscox Ltd

Johnson Matthey PLC

Persimmon PLC

-------

FTSE 250 Adds:

-------

888 Holdings PLC

Abrdn PLC

Breedon Group PLC

CAB Payments Holdings PLC

Ceres Power Holdings PLC

Foresight Group Holdings Ltd

Hiscox Ltd

Johnson Matthey PLC

Moonpig Group PLC

Persimmon PLC

-------

FTSE 250 Deletes:

-------

Capita PLC

CMC Markets PLC

Dechra Pharmaceuticals PLC

Diploma PLC

Hikma Pharmaceuticals PLC

Marks & Spencer Group PLC

Molten Ventures PLC

Synthomer PLC

Vanquis Banking Group PLC

Warehouse REIT PLC

-------

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
22 Feb 2021 08:43

Dechra Pharmaceuticals' interim revenues and profits improve

(Sharecast News) - Drugmaker Dechra Pharmaceuticals said on Monday that reported group revenues and operating profits had both increased throughout the six months ended 31 December.

Read more
22 Feb 2021 08:28

Companion Animal Products Boost Lifts Dechra's Half-Year Profit

Companion Animal Products Boost Lifts Dechra's Half-Year Profit

Read more
15 Feb 2021 15:58

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
8 Feb 2021 08:41

Dechra Pharmaceuticals In Tri-Solfen Deal, Ups Medical Ethics Stake

Dechra Pharmaceuticals In Tri-Solfen Deal, Ups Medical Ethics Stake

Read more
8 Feb 2021 07:54

Dechra secures last international rights to Tri-Solfen

(Sharecast News) - Dechra Pharmaceuticals announced on Monday that it has secured the rights to market Tri-Solfen in Australia and New Zealand. and has acquired a further 1.5% of Medical Ethics for AUD 32.5m (£18.1m).

Read more
14 Jan 2021 10:34

Dechra Pharmaceuticals Ahead Of Expectations Despite Uncertainty

Dechra Pharmaceuticals Ahead Of Expectations Despite Uncertainty

Read more
26 Nov 2020 13:57

Thursday broker round-up

(Sharecast News) - AO World: Jefferies downgrades to hold with a target price of 378p.

Read more
26 Nov 2020 10:31

JP Morgan raises target price on Dechra Pharmaceuticals

(Sharecast News) - Analysts at JP Morgan Cazenove raised their target price on veterinary pharmaceuticals group Dechra from 3,200.0p to 3,600.0p on Thursday, stating they expect a year of "strong topline growth" to take place in 2021.

Read more
26 Nov 2020 09:41

UK BROKER RATINGS SUMMARY: Goldman Cuts CRH; Morgan Stanley Lifts DCC

UK BROKER RATINGS SUMMARY: Goldman Cuts CRH; Morgan Stanley Lifts DCC

Read more
20 Nov 2020 16:06

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
20 Nov 2020 09:35

UK BROKER RATINGS SUMMARY: Citigroup Lifts Croda To Buy From Neutral

UK BROKER RATINGS SUMMARY: Citigroup Lifts Croda To Buy From Neutral

Read more
18 Nov 2020 12:42

DIRECTOR DEALINGS: Dechra Pharma CEO Sells GBP10 Million In Shares

DIRECTOR DEALINGS: Dechra Pharma CEO Sells GBP10 Million In Shares

Read more
29 Oct 2020 16:01

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
27 Oct 2020 09:36

Dechra Pharmaceuticals Makes Strong Start To Year But Outlook Unclear

Dechra Pharmaceuticals Makes Strong Start To Year But Outlook Unclear

Read more
21 Oct 2020 09:33

UK BROKER RATINGS SUMMARY: StanChart Raised; Jefferies Says Buy Metro

UK BROKER RATINGS SUMMARY: StanChart Raised; Jefferies Says Buy Metro

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.